Positron Corporation Announces Attrius® PET System Sale
November 24, 2023 10:00 ET
|
Positron Corp.
Niagara Falls, NY, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET imaging systems...
Positron Corporation Announces Attrius® PET System Sale
October 04, 2023 10:48 ET
|
Positron Corp.
Niagara Falls, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET imaging systems...
Positron Corporation Announces Start of Clinical Study of Affinity PET-CT Device
September 08, 2023 08:00 ET
|
Positron Corp.
Niagara Falls, NY, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company, is pleased to announce that...
Positron Corporation Orders Six Attrius® PET Systems and Components from Neusoft Positron Medical Systems
July 31, 2023 08:00 ET
|
Positron Corp.
Niagara Falls, NY, July 31, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company that manufactures, sells and...
Positron Corporation Enters New Manufacturing & Components Supplier Cooperative with Neusoft Medical Systems Subsidiary for New PET-CT Device
July 21, 2023 10:35 ET
|
Positron Corp.
Niagara Falls, NY, July 21, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company, is pleased to announce that...
Positron Corporation Enters into Agreement with Ochsner Clinic Foundation for Clinical Study of its New “Affinity PET-CT 4D” Device
March 01, 2023 09:37 ET
|
Positron Corp.
Niagara Falls, NY, March 01, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a molecular imaging device company that offers PET imaging systems and clinical...
Positron Corporation Announces Plans for Clinical Study of its New “Affinity PET-CT 4D” Nuclear Imaging Device
December 20, 2022 10:58 ET
|
Positron Corp.
Niagara Falls, NY, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging systems and clinical services company, is pleased...
Positron Corporation Announces First Step in Validation of its New PET-CT Device
August 16, 2022 10:47 ET
|
Positron Corp.
Niagara Falls, NY, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging device systems and clinical services company, is...
Positron Corporation Announces Key Sales & Services Personnel Hire
June 24, 2022 11:25 ET
|
Positron Corp.
Niagara Falls, NY, June 24, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging device systems and clinical services company, is...
Positron Corporation Retains FDA Consulting Firm in Preparation for 510K New Device Application
February 17, 2022 14:17 ET
|
Positron Corp.
Niagara Falls, NY , Feb. 17, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging device systems and clinical services company, is...